Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease isolated polycystic liver disease
Comorbidity C0022679|cystic kidney
Sentences 3
PubMedID- 22773240 Background: we showed in a randomized double-blinded placebo-controlled clinical trial that octreotide long-acting repeatable depot.(r) (octlar((r))) for 12 months reduces kidney and liver growth in autosomal dominant polycystic kidney patients with severe polycystic liver disease (pld) and liver growth in patients with severe isolated pld.
PubMedID- 24987537 Combined liver and kidney transplant in a patient with budd-chiari syndrome secondary to autosomal dominant polycystic kidney disease associated with polycystic liver disease: report of a case with a 9-year follow-up.
PubMedID- 23499726 Background & aims: polycystic liver disease (pld) is associated with autosomal dominant polycystic kidney disease (adpkd) or autosomal dominant polycystic liver disease (pcld).

Page: 1